Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Gender differences in the epidemiology and treatment of anxiety disorders
Autore:
Pigott, TA;
Indirizzi:
Univ Texas, Med Branch, Dept Psychiat & Behav Sci, Galveston, TX 77550 USAUniv Texas Galveston TX USA 77550 at & Behav Sci, Galveston, TX 77550 USA
Titolo Testata:
JOURNAL OF CLINICAL PSYCHIATRY
, volume: 60, anno: 1999, supplemento:, 18
pagine: 4 - 15
SICI:
0160-6689(1999)60:<4:GDITEA>2.0.ZU;2-L
Fonte:
ISI
Lingua:
ENG
Soggetto:
OBSESSIVE-COMPULSIVE-DISORDER; PSYCHOTROPIC-DRUG USE; POSTTRAUMATIC-STRESS-DISORDER; PARTLY DIFFERENT ENVIRONMENTS; ORAL-CONTRACEPTIVE STEROIDS; NATIONAL-COMORBIDITY-SURVEY; QUALITY-OF-LIFE; PANIC DISORDER; SOCIAL PHOBIA; MAJOR DEPRESSION;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Social & Behavioral Sciences
Clinical Medicine
Citazioni:
145
Recensione:
Indirizzi per estratti:
Indirizzo: Pigott, TA Univ Texas, Med Branch, Dept Psychiat & Behav Sci, Rebecca Sealy Hosp 4 510, 404 Univ Blvd, Galveston, TX 77555 USA Univ Texas 404 Univ Blvd Galveston TX USA 77555 n, TX 77555 USA
Citazione:
T.A. Pigott, "Gender differences in the epidemiology and treatment of anxiety disorders", J CLIN PSY, 60, 1999, pp. 4-15

Abstract

Women are more likely than men to develop anxiety disorders. Yet, relatively few studies have investigated whether women with anxiety disorders have characteristics that are distinct from those of men with the same disorders. The cause of the enhanced vulnerability to anxiety for women remains largely undetermined. Recent data suggest that female reproductive hormones andrelated cycles may play an important role. In addition to etiologic functions, reproductive hormones may substantially influence the clinical course of preexisting anxiety conditions in women. Psychotropic medications are more likely to be prescribed to women, and gender differences have been identified in the pharmacokinetics of psychotropic medication. Yet, relatively few systematic data are available concerning the potential clinical relevance or possible treatment implications of gender differences in the treatmentof women with anxiety disorders. This article reviews the unique characteristics of primary anxiety disorders in women, summarizes the neurobiological effects associated with estrogen and progesterone, discusses gender differences in medication metabolism and the potential relevance of these differences in the pharmacologic management of women with anxiety disorders, and reviews issues specific to women (e.g., hormone therapy, oral contraceptives, menstrual cycle, pregnancy, lactation) that may impact treatment with psychotropic medication.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/07/20 alle ore 20:59:26